Long term clinical benefit of lenalidomide (Revlimid) treatment in patients with myelodysplastic syndrome without del 5q cytogenetic abnormalities Meeting Abstract
| Authors: | Raza, A.; Reeves, J. E.; Feldman, E. J.; Deeg, H. J.; Dreisbach, L.; Schiffer, C. A.; Shammo, J. M.; Klimek, V. M.; Greenberg, P. L.; Bennett, J. M.; Dewald, G. W.; Zeldis, J. B.; Wride, K.; Schmidt, M.; Knight, R. D.; List, A. F. |
| Abstract Title: | Long term clinical benefit of lenalidomide (Revlimid) treatment in patients with myelodysplastic syndrome without del 5q cytogenetic abnormalities |
| Meeting Title: | 48th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 108 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2006 Dec 9-12 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2006-11-01 |
| Start Page: | 78A |
| Language: | English |
| ACCESSION: | WOS:000242440000251 |
| PROVIDER: | wos |
| PUBMED: | 17139767 |
| DOI: | 10.1182/blood.V108.11.250.250 |
| Notes: | --- - Meeting Abstract: 250 - 48th Annual Meeting of the American-Society-of-Hematology - DEC 09-12, 2006 - Orlando, FL - Part 1 - "Source: Wos" |
